The results of an older patient's urinalysis reveal bacteria in the urine. What action should the ...

The results of an older patient's urinalysis reveal bacteria in the urine. What action should the nurse perform next?
 
  1. Notify the physician.
  2. Order a repeat urinalysis to confirm the initial test.
  3. Order a culture and sensitivity to identify the exact type of bacteria.
  4. Review the nursing assessment for reports consistent with a urinary tract infection.

Question 2

Tuberculosis
 
  A) can be spread by persons who have positive skin tests and no symptoms.
  B) presents a higher risk for clients who take immunosuppressant medications.
  C) is caused by a virus related to human immunodeficiency virus (HIV).
  D) in the early stage, causes the client to gain weight and be short of breath.

Question 3

An older patient tells the nurse about leaking urine when sneezing. To what does the nurse realize that is type of urinary incontinence is attributed?
 
  1. Result of a system blockage
  2. Result of bladder overstretching
  3. Damage of the urinary apparatus
  4. Increase in intra-abdominal pressure

Question 4

An active case of tuberculosis
 
  A) is treated with several antibiotics for a 2-month period.
  B) gives active immunity and the client cannot have a relapse.
  C) is verified by a positive two-step tuberculin skin test.
  D) requires isolation with controlled ventilation and reverse airflow until the client has been treated for 2 weeks with recommended antibiotic therapy.

Question 5

An elderly client has an order for a tuberculin skin test. The correct technique to give the two-step test purified protein derivative (PP
  D) is to
 
  A) administer an injection of 5-TU subcutaneously; observe for induration in 48 hours; repeat the test and measure the induration.
  B) administer an injection of 5-TU intradermally and measure the induration in 72 hours; if the test is negative, repeat the test within 1 to 2 weeks and measure the induration in 72 hours.
  C) administer 5 units of BCG vaccine subcutaneously; in 72 hours administer an injection of 5-TU intradermally and measure the induration in 24 hours. Repeat the test in two weeks.
  D) administer an injection of 5-TU intradermally at one site and administer an injection of 5-TU subcutaneously and measure the induration of both sites in 72 hours.